Du Jian, Stankiewicz Monika J, Liu Yang, Xi Qing, Schmitz Jonathan E, Lekstrom-Himes Julie A, Ackerman Steven J
Department of Biochemistry and Molecular Biology, College of Medicine, University of Illinois, Chicago, Illinois 60612, USA.
J Biol Chem. 2002 Nov 8;277(45):43481-94. doi: 10.1074/jbc.M204777200. Epub 2002 Aug 28.
GATA-1 and the ets factor PU.1 have been reported to functionally antagonize one another in the regulation of erythroid versus myeloid gene transcription and development. The CCAAT enhancer binding protein epsilon (C/EBPepsilon) is expressed as multiple isoforms and has been shown to be essential to myeloid (granulocyte) terminal differentiation. We have defined a novel synergistic, as opposed to antagonistic, combinatorial interaction between GATA-1 and PU.1, and a unique repressor role for certain C/EBPepsilon isoforms in the transcriptional regulation of a model eosinophil granulocyte gene, the major basic protein (MBP). The eosinophil-specific P2 promoter of the MBP gene contains GATA-1, C/EBP, and PU.1 consensus sites that bind these factors in nuclear extracts of the eosinophil myelocyte cell line, AML14.3D10. The promoter is transactivated by GATA-1 alone but is synergistically transactivated by low levels of PU.1 in the context of optimal levels of GATA-1. The C/EBPepsilon(27) isoform strongly represses GATA-1 activity and completely blocks GATA-1/PU.1 synergy. In vitro mutational analyses of the MBP-P2 promoter showed that both the GATA-1/PU.1 synergy, and repressor activity of C/EBPepsilon(27) are mediated via protein-protein interactions through the C/EBP and/or GATA-binding sites but not the PU.1 sites. Co-immunoprecipitations using lysates of AML14.3D10 eosinophils show that both C/EBPepsilon(32/30) and epsilon(27) physically interact in vivo with PU.1 and GATA-1, demonstrating functional interactions among these factors in eosinophil progenitors. Our findings identify novel combinatorial protein-protein interactions for GATA-1, PU.1, and C/EBPepsilon isoforms in eosinophil gene transcription that include GATA-1/PU.1 synergy and repressor activity for C/EBPepsilon(27).
据报道,GATA-1和ets因子PU.1在红系与髓系基因转录及发育的调控中存在功能上的相互拮抗。CCAAT增强子结合蛋白ε(C/EBPε)以多种异构体形式表达,并且已被证明对髓系(粒细胞)终末分化至关重要。我们定义了GATA-1和PU.1之间一种新型的协同(而非拮抗)组合相互作用,以及某些C/EBPε异构体在模型嗜酸性粒细胞基因——主要碱性蛋白(MBP)转录调控中的独特抑制作用。MBP基因的嗜酸性粒细胞特异性P2启动子包含GATA-1、C/EBP和PU.1共有位点,这些位点在嗜酸性粒细胞髓细胞系AML14.3D10的核提取物中与这些因子结合。该启动子单独被GATA-1反式激活,但在GATA-1最佳水平的情况下,低水平的PU.1可协同反式激活它。C/EBPε(27)异构体强烈抑制GATA-1活性并完全阻断GATA-1/PU.1协同作用。对MBP-P2启动子的体外突变分析表明,GATA-1/PU.1协同作用以及C/EBPε(27)的抑制活性均通过C/EBP和/或GATA结合位点的蛋白质-蛋白质相互作用介导,而非通过PU.1位点。使用AML14.3D10嗜酸性粒细胞裂解物进行的共免疫沉淀表明,C/EBPε(32/30)和ε(27)在体内均与PU.1和GATA-1发生物理相互作用,证明了这些因子在嗜酸性粒细胞祖细胞中的功能相互作用。我们的研究结果确定了GATA-1、PU.1和C/EBPε异构体在嗜酸性粒细胞基因转录中的新型组合蛋白质-蛋白质相互作用,其中包括GATA-1/PU.1协同作用以及C/EBPε(27)的抑制活性。